ATE456659T1 - Streptococcus pyogenes polypeptide und entsprechende dna fragmente - Google Patents

Streptococcus pyogenes polypeptide und entsprechende dna fragmente

Info

Publication number
ATE456659T1
ATE456659T1 AT02701124T AT02701124T ATE456659T1 AT E456659 T1 ATE456659 T1 AT E456659T1 AT 02701124 T AT02701124 T AT 02701124T AT 02701124 T AT02701124 T AT 02701124T AT E456659 T1 ATE456659 T1 AT E456659T1
Authority
AT
Austria
Prior art keywords
streptococcus pyogenes
dna fragments
corresponding dna
pyogenes polypeptides
polypeptides
Prior art date
Application number
AT02701124T
Other languages
English (en)
Inventor
Denis Martin
Stephane Rioux
Bernard Brodeur
Josee Hamel
Patrick Rheault
Original Assignee
Id Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Id Biomedical Corp filed Critical Id Biomedical Corp
Application granted granted Critical
Publication of ATE456659T1 publication Critical patent/ATE456659T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT02701124T 2001-02-21 2002-02-21 Streptococcus pyogenes polypeptide und entsprechende dna fragmente ATE456659T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26984001P 2001-02-21 2001-02-21
PCT/CA2002/000207 WO2002066650A2 (en) 2001-02-21 2002-02-21 Streptococcus pyogenes polypeptides and corresponding dna fragments

Publications (1)

Publication Number Publication Date
ATE456659T1 true ATE456659T1 (de) 2010-02-15

Family

ID=23028867

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02701124T ATE456659T1 (de) 2001-02-21 2002-02-21 Streptococcus pyogenes polypeptide und entsprechende dna fragmente

Country Status (10)

Country Link
US (2) US7482012B2 (de)
EP (1) EP1362106B1 (de)
JP (1) JP4281861B2 (de)
AT (1) ATE456659T1 (de)
AU (1) AU2002234455C1 (de)
BR (1) BRPI0207447B1 (de)
CA (1) CA2438921C (de)
DE (1) DE60235223D1 (de)
ES (1) ES2338637T3 (de)
WO (1) WO2002066650A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1343895B1 (de) * 2000-12-21 2008-06-18 ID Biomedical Corporation Antigene aus streptococcus pyogenes und zugehörige dna-fragmente
AU2008207670B2 (en) * 2001-04-13 2011-06-16 Wyeth Surface proteins of streptococcus pyogenes
EP1390505A2 (de) * 2001-05-02 2004-02-25 Shire Biochem Inc. Antigene von streptococcus gruppe b und zugehörige dna-fragmente
ATE361097T1 (de) * 2002-01-15 2007-05-15 Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh Orale vakzinierung mit dem tumor-antigen-mimotop gln-met-trp-ala-pro-gln-trp-gly-pro-asp
CN1756843B (zh) * 2003-03-04 2012-03-21 英特塞尔股份公司 化脓链球菌抗原
US7635487B2 (en) 2003-04-15 2009-12-22 Intercell Ag S. pneumoniae antigens
CA2535863A1 (en) * 2003-08-15 2005-02-24 Id Biomedical Corporation Polypeptides of streptococcus pyogenes
KR101163425B1 (ko) 2006-04-14 2012-07-13 닛본 덴끼 가부시끼가이샤 개체 식별 방법 및 장치

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040144A (en) * 1997-07-25 2000-03-21 Mount Sinai School Of Medicine Procedure for preparing gene expression libraries enriched for secretory protein genes
US6033673A (en) * 1998-03-18 2000-03-07 The Administrators Of Tulane Educational Fund Double mutant enterotoxin for use as an adjuvant
GB9807890D0 (en) * 1998-04-09 1998-06-10 Actinova Ltd Peptides
GB9921125D0 (en) * 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
US7939087B2 (en) 2000-10-27 2011-05-10 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from Streptococcus groups A & B
FR2824074A1 (fr) 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
EP1390505A2 (de) 2001-05-02 2004-02-25 Shire Biochem Inc. Antigene von streptococcus gruppe b und zugehörige dna-fragmente
GB0210128D0 (en) 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
CN1756843B (zh) 2003-03-04 2012-03-21 英特塞尔股份公司 化脓链球菌抗原

Also Published As

Publication number Publication date
AU2002234455C1 (en) 2008-08-21
CA2438921C (en) 2012-04-10
AU2002234455B2 (en) 2008-01-17
US20090186820A1 (en) 2009-07-23
WO2002066650A3 (en) 2002-10-31
CA2438921A1 (en) 2002-08-29
JP2004531235A (ja) 2004-10-14
ES2338637T3 (es) 2010-05-11
JP4281861B2 (ja) 2009-06-17
US20030049271A1 (en) 2003-03-13
EP1362106B1 (de) 2010-01-27
DE60235223D1 (de) 2010-03-18
WO2002066650A2 (en) 2002-08-29
US7883706B2 (en) 2011-02-08
EP1362106A2 (de) 2003-11-19
BR0207447A (pt) 2004-06-29
BRPI0207447B1 (pt) 2015-09-22
US7482012B2 (en) 2009-01-27

Similar Documents

Publication Publication Date Title
FR21C1005I2 (fr) Antigenes de streptococcus pyogenes et fragments d'adn correspondants
DK1129190T3 (da) Human TSLP DNA og polypeptider
IL264925A (en) Isolated or recombinant proteins that induce an immune response against S. PYOGENES, preparations containing them and their uses
WO2003054007A3 (en) Streptococcus antigens
ATE376591T1 (de) Neisseria meningitidis antigene und zusammenstellungen
EP2336174B8 (de) Humane monoklonale Antikörper gegen Hendra- und Nipah-Viren
WO2005056600A3 (en) Monoclonal antibodies that bind or neutralize dengue virus
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
MXPA03000103A (es) Antigenos de streptococcus.
MX2024007966A (es) Anticuerpos anti-tslp novedosos.
MXPA03009294A (es) Proteinas de superficie de streptococcus pyogenes.
NO20004161L (no) Gruppe B streptokoccus antigener
DE60045721D1 (de) Streptococcus pneumoniae Proteine und Impfstoffe
AU7227001A (en) Streptococcus pyogenes antigens
WO2001081380A3 (en) Immunogenic pneumococcal protein and vaccine compositions thereof
DE60235223D1 (de) Streptococcus pyogenes polypeptide und entsprechende dna fragmente
ATE321853T1 (de) Humanische pellino-polypeptide
DE69637640D1 (de) N und anwendungen
IL156799A0 (en) Peptides having affinity for the gp120 viral protein and use thereof
WO2003068813A3 (en) Group b streptococcus antigen
DE60234772D1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente
WO2002092625A3 (en) Moraxella(branhamella) catarrhalis antigens
WO2002079475A3 (en) Streptococcus pyogenes antigens and corresponding dna fragments
WO2002102836A3 (en) Moraxella (branhamella) catarrhalis antigens
TW200500465A (en) Novel humanized anti-vap-1 monoclonal antibody

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties